Literature DB >> 1569952

The HIP1 initiator element plays a role in determining the in vitro requirement of the dihydrofolate reductase gene promoter for the C-terminal domain of RNA polymerase II.

A B Buermeyer1, N E Thompson, L A Strasheim, R R Burgess, P J Farnham.   

Abstract

We examined the ability of purified RNA polymerase (RNAP) II lacking the carboxy-terminal heptapeptide repeat domain (CTD), called RNAP IIB, to transcribe a variety of promoters in HeLa extracts in which endogenous RNAP II activity was inhibited with anti-CTD monoclonal antibodies. Not all promoters were efficiently transcribed by RNAP IIB, and transcription did not correlate with the in vitro strength of the promoter or with the presence of a consensus TATA box. This was best illustrated by the GC-rich, non-TATA box promoters of the bidirectional dihydrofolate reductase (DHFR)-REP-encoding locus. Whereas the REP promoter was transcribed by RNAP IIB, the DHFR promoter remained inactive after addition of RNAP IIB to the antibody-inhibited reactions. However, both promoters were efficiently transcribed when purified RNAP with an intact CTD was added. We analyzed a series of promoter deletions to identify which cis elements determine the requirement for the CTD of RNAP II. All of the promoter deletions of both DHFR and REP retained the characteristics of their respective full-length promoters, suggesting that the information necessary to specify the requirement for the CTD is contained within approximately 65 bp near the initiation site. Furthermore, a synthetic minimal promoter of DHFR, consisting of a single binding site for Sp1 and a binding site for the HIP1 initiator cloned into a bacterial vector sequence, required RNAP II with an intact CTD for activity in vitro. Since the synthetic minimal promoter of DHFR and the smallest REP promoter deletion are both activated by Sp1, the differential response in this assay does not result from upstream activators. However, the sequences around the start sites of DHFR and REP are not similar and our data suggest that they bind different proteins. Therefore, we propose that specific initiator elements are important for determination of the requirement of some promoters for the CTD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569952      PMCID: PMC364397          DOI: 10.1128/mcb.12.5.2250-2259.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Molecular organization of the human Raf-1 promoter region.

Authors:  T W Beck; U Brennscheidt; G Sithanandam; J Cleveland; U R Rapp
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

2.  Phosphorylation of RNA polymerase IIA occurs subsequent to interaction with the promoter and before the initiation of transcription.

Authors:  P J Laybourn; M E Dahmus
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

Review 3.  RNA polymerase B (II) and general transcription factors.

Authors:  M Sawadogo; A Sentenac
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

4.  Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography. Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody.

Authors:  N E Thompson; D B Aronson; R R Burgess
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

5.  Sequences downstream of the transcription initiation site modulate the activity of the murine dihydrofolate reductase promoter.

Authors:  P J Farnham; A L Means
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

6.  In vitro transcription and delimitation of promoter elements of the murine dihydrofolate reductase gene.

Authors:  P J Farnham; R T Schimke
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

7.  Tagetitoxin: a new inhibitor of eukaryotic transcription by RNA polymerase III.

Authors:  T H Steinberg; D E Mathews; R D Durbin; R R Burgess
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

8.  Transcription of adenovirus-2 major late promoter inhibited by monoclonal antibody directed against RNA polymerases IIO and IIA.

Authors:  M E Dahmus; C Kedinger
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Purification using polyethylenimine precipitation and low molecular weight subunit analyses of calf thymus and wheat germ DNA-dependent RNA polymerase II.

Authors:  H G Hodo; S P Blatti
Journal:  Biochemistry       Date:  1977-05-31       Impact factor: 3.162

View more
  19 in total

1.  hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.

Authors:  M K Kim; V M Nikodem
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 2.  RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.

Authors:  Gregory Prelich
Journal:  Eukaryot Cell       Date:  2002-04

3.  Inhibition of basal transcription by poliovirus: a virus- encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro.

Authors:  P Yalamanchili; K Harris; E Wimmer; A Dasgupta
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Myc versus USF: discrimination at the cad gene is determined by core promoter elements.

Authors:  K E Boyd; P J Farnham
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

5.  Repression of TFIIH transcriptional activity and TFIIH-associated cdk7 kinase activity at mitosis.

Authors:  J J Long; A Leresche; R W Kriwacki; J M Gottesfeld
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.

Authors:  H Okamoto; C T Sheline; J L Corden; K A Jones; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants.

Authors:  R J Miltenberger; K A Sukow; P J Farnham
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

8.  A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription.

Authors:  T P Mäkelä; J D Parvin; J Kim; L J Huber; P A Sharp; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

9.  Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast.

Authors:  J B McNeil; H Agah; D Bentley
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

10.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain.

Authors:  R Baskaran; M E Dahmus; J Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.